AUTHORS' REPLY

Por Webb, AK, Bilton, D
Publicado em 1991

New treatments in adult cystic fibrosis.

Por Bilton, D, Mahadeva, R
Publicado em 1997

Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis

Por Parmar, J, Howell, T, Kelly, J, Bilton, D
Publicado em 2002

Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease

Por Mahadeva, R, Stewart, S, Bilton, D, Lomas, D
Publicado em 1998

Chronic Burkholderia multivorans bronchial infection in a non-cystic fibrosis individual with mannose binding lectin deficiency

Por Whitehouse, J, Exley, A, Foweraker, J, Bilton, D
Publicado em 2005

Treatment compliance in adults with cystic fibrosis.

Por Abbott, J., Dodd, M., Bilton, D., Webb, A. K.
Publicado em 1994

Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis.

Por Salh, W, Bilton, D, Dodd, M, Webb, A K
Publicado em 1989

Life threatening haemoptysis in cystic fibrosis: an alternative therapeutic approach.

Por Bilton, D, Webb, A K, Foster, H, Mulvenna, P, Dodd, M
Publicado em 1990

RISK OF HEMOPTYSIS IN CYSTIC FIBROSIS CLINICAL TRIALS: A RETROSPECTIVE COHORT STUDY

Por Thompson, V., Mayer-Hamblett, N., Kloster, M., Bilton, D., Flume, P. A.
Publicado no J Cyst Fibros (2015)

Mediterranean Europe as an area of endemism for small mammals rather than a source for northwards postglacial colonization.

Por Bilton, D T, Mirol, P M, Mascheretti, S, Fredga, K, Zima, J, Searle, J B
Publicado em 1998

Association of α(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis

Por Mahadeva, R, Sharples, L, Ross-Russell, R, Webb, A, Bilton, D, Lomas, D
Publicado em 2001

A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic

Por Sharples, L, Edmunds, J, Bilton, D, Hollingworth, W, Caine, N, Keogan, M, Exley, A
Publicado em 2002

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis

Por Elborn, JS, Horsley, A, MacGregor, G, Bilton, D, Grosswald, R, Ahuja, S, Springman, EB
Publicado no Clin Transl Sci (2016)

Pathology of common bile duct stenosis in cystic fibrosis.

Por Bilton, D, Fox, R, Webb, A K, Lawler, W, McMahon, R F, Howat, J M
Publicado em 1990

Influenza vaccination in adults with cystic fibrosis.

Por Ong, E L, Bilton, D, Abbott, J, Webb, A K, McCartney, R A, Caul, E O
Publicado em 1991

Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007

Por George, P M, Banya, W, Pareek, N, Bilton, D, Cullinan, P, Hodson, M E, Simmonds, N J
Publicado em 2011

Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease

Por Mahadeva, R, Dunn, A C, Westerbeek, R C, Sharples, L, Whitehouse, D B, Carroll, N R, Ross-Russell, R I, Webb, A K, Bilton, D, Lomas, D A, Lockwood, C M
Publicado em 1999